Glenview Capital Management, LLC Abb Vie Inc. Transaction History

Glenview Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $126 Million - $168 Million	-1,364,449 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $356 Million - $391 Million	-3,976,883 Reduced 74.45%	1,364,449 $132 Million
Q3 2017 Nov 14, 2017	SELL	$69.85 - $89.22 $53.7 Million - $68.6 Million	-768,838 Reduced 12.58%	5,341,332 $475 Million
Q2 2017 Aug 14, 2017	BUY	N/A	6,110,170	6,110,170 $443 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Glenview Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Glenview Capital Management, LLC with notifications on news.